109 related articles for article (PubMed ID: 6165750)
1. Histamine suppression of in vivo eosinophil accumulation and histamine release in human allergic reactions.
Ting S; Zweiman B; Lavker R; Dunsky EH
J Allergy Clin Immunol; 1981 Jul; 68(1):65-71. PubMed ID: 6165750
[TBL] [Abstract][Full Text] [Related]
2. In vivo release of eosinophil chemoattractant activity in human allergic skin reactions.
Ting S; Zweiman B; Lavker RM; Dunsky EH
J Immunol; 1981 Aug; 127(2):557-60. PubMed ID: 7252149
[TBL] [Abstract][Full Text] [Related]
3. Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions.
Ting S; Dunsky EH; Lavker RM; Zweiman B
J Allergy Clin Immunol; 1980 Nov; 66(5):417-23. PubMed ID: 6160172
[TBL] [Abstract][Full Text] [Related]
4. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions.
Zweiman B; Atkins PC; von Allmen C; Gleich GJ
J Allergy Clin Immunol; 1991 May; 87(5):984-92. PubMed ID: 1709185
[TBL] [Abstract][Full Text] [Related]
5. Effect of cimetidine on exogenous histamine inhibition of histamine release in vivo.
Ting S; Zweiman B; Lavker RM; Dunsky EH
Allergy; 1983 Jan; 38(1):11-7. PubMed ID: 6188385
[TBL] [Abstract][Full Text] [Related]
6. Terbutaline modulation of human allergic skin reactions.
Ting S; Zweiman B; Lavker R
J Allergy Clin Immunol; 1983 May; 71(5):437-41. PubMed ID: 6188770
[TBL] [Abstract][Full Text] [Related]
7. The effects of gender on allergen-induced histamine release in ongoing allergic cutaneous reactions.
Atkins PC; von Allmen C; Valenzano M; Zweiman B
J Allergy Clin Immunol; 1993 May; 91(5):1031-4. PubMed ID: 7684052
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.
Charlesworth EN; Hood AF; Soter NA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Clin Invest; 1989 May; 83(5):1519-26. PubMed ID: 2468688
[TBL] [Abstract][Full Text] [Related]
9. Correlations of in vivo mediator release with late cutaneous allergic responses in humans. I. Kinetics of histamine release.
Talbot SF; Atkins PC; Valenzano M; Zweiman B
J Allergy Clin Immunol; 1984 Dec; 74(6):819-26. PubMed ID: 6209324
[TBL] [Abstract][Full Text] [Related]
10. Patterns of inflammatory responses following rechallenge of skin late-phase allergic reaction sites.
Zweiman B; von Allmen C; Schwartz LB; Atkins PC
J Allergy Clin Immunol; 1998 Jul; 102(1):94-8. PubMed ID: 9679852
[TBL] [Abstract][Full Text] [Related]
11. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
12. In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells.
Amon U; Gibbs BF; Buss G; Nitschke M
Inflamm Res; 2000 Mar; 49(3):112-6. PubMed ID: 10807498
[TBL] [Abstract][Full Text] [Related]
13. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.
Charlesworth EN; Kagey-Sobotka A; Schleimer RP; Norman PS; Lichtenstein LM
J Immunol; 1991 Jan; 146(2):671-6. PubMed ID: 1702812
[TBL] [Abstract][Full Text] [Related]
14. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of hydroxyzine on antigen-induced histamine release in vivo.
Ting S; Rauls DO; Reiman BE
J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):63-6. PubMed ID: 2578493
[TBL] [Abstract][Full Text] [Related]
16. Failure of Verapamil in inhibiting allergen-induced histamine release in vivo.
Ting S; Mansfield LE; Rauls DO
Allergy; 1985 Oct; 40(7):519-22. PubMed ID: 2416233
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 is released at sites of human cutaneous allergic reactions.
Bochner BS; Charlesworth EN; Lichtenstein LM; Derse CP; Gillis S; Dinarello CA; Schleimer RP
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):830-9. PubMed ID: 2262641
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of leukotriene C4 and histamine in human allergic skin reactions.
Talbot SF; Atkins PC; Goetzl EJ; Zweiman B
J Clin Invest; 1985 Aug; 76(2):650-6. PubMed ID: 2411760
[TBL] [Abstract][Full Text] [Related]
20. Determinants of in vivo histamine release in cutaneous allergic reactions in humans.
Atkins PC; von Allmen C; Valenzano M; Olson R; Shalit M; Zweiman B
J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):371-9. PubMed ID: 1698846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
